In our study, PIL was detected in 2.7% of patients with HCC, showing a higher prevalence compared with other non-head and neck primary cancers, and a higher likelihood of detection in patients with head and neck cancer (2.1%) [3]. This evidence concerns the gene SERPINA2 and hepatocellular carcinoma.